Medicare Enrolled

Dr. Kisha Young, M.D., PH.D.

Neurology · Austell, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Research-focused
4460 AUSTELL RD, Austell, GA 30106
7709443616
In practice since 2013 (13 years)
NPI: 1740627991 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Young from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Young? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Young

Dr. Kisha Young is a neurology specialist in Austell, GA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Young performed 535 Medicare services across 378 unique beneficiaries.

Between the years covered by Open Payments, Dr. Young received a total of $85,215 from 48 pharmaceutical and/or device companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Young is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 44% volume in GA $85,215 industry payments

Medicare Practice Summary

Medicare Utilization ↗
535
Medicare services
Top 44% in GA for neurology
378
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~41 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
137 $61 $178
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
109 $132 $387
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
105 $88 $284
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
80 $91 $335
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
63 $90 $261
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
30 $134 $458
New patient office visit, complex (60-74 min) 11 $164 $476
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$85,215
Total received (2018-2024)
Avg $12,174/year across 7 years
Top 7% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
386
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$49,907 (58.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,381 (16.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,398 (14.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,529 (10.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$21,767
2023
$5,277
2022
$1,961
2021
$2,085
2020
$1,415
2019
$24,146
2018
$28,564

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$11,426
Kyowa Kirin, Inc.
$7,877
MDD US Operations, LLC
$420
ABBVIE INC.
$267
Alexion Pharmaceuticals, Inc.
$219
Amneal Pharmaceuticals LLC
$147
ACADIA Pharmaceuticals Inc
$145
Biogen, Inc.
$141
Teva Pharmaceuticals USA, Inc.
$141
Lilly USA, LLC
$102
UCB, Inc.
$96
Mallinckrodt Hospital Products Inc.
$95
PFIZER INC.
$79
Eisai Inc.
$79
Supernus Pharmaceuticals, Inc.
$76
Lundbeck LLC
$66
Neurelis, Inc.
$63
ARGENX US, INC.
$62
JAZZ PHARMACEUTICALS INC.
$51
Grifols USA, LLC
$44
Acorda Therapeutics, Inc
$35
Novartis Pharmaceuticals Corporation
$28
Aucta Pharmaceuticals, Inc.
$25
CATALYST PHARMACEUTICALS, INC.
$24
SK Life Science, Inc.
$23
HARMONY BIOSCIENCES LLC
$22
ANI Pharmaceuticals, Inc.
$16
Top 3 companies account for 90.6% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$43,658
Neurocrine Biosciences, Inc.
$14,192
Kyowa Kirin, Inc.
$10,543
AbbVie, Inc.
$6,249
Lundbeck LLC
$2,274
Acorda Therapeutics, Inc
$1,277
ACADIA Pharmaceuticals Inc
$1,220
Teva Pharmaceuticals USA, Inc.
$1,007
MDD US Operations, LLC
$511
ABBVIE INC.
$408
Amneal Pharmaceuticals LLC
$356
Boston Scientific Corporation
$353
Alexion Pharmaceuticals, Inc.
$326
AbbVie Inc.
$310
UCB, Inc.
$278
Lilly USA, LLC
$213
Amgen Inc.
$181
Medtronic, Inc.
$169
Biogen, Inc.
$161
Merz Pharmaceuticals, LLC
$118
PFIZER INC.
$111
Neurelis, Inc.
$109
Supernus Pharmaceuticals, Inc.
$103
Mallinckrodt Hospital Products Inc.
$95
Eisai Inc.
$94
ARGENX US, INC.
$85
GENZYME CORPORATION
$85
Adamas Pharmaceuticals, Inc.
$73
SK Life Science, Inc.
$65
UPSHER-SMITH LABORATORIES LLC
$57
Allergan, Inc.
$54
Sunovion Pharmaceuticals Inc.
$51
JAZZ PHARMACEUTICALS INC.
$51
Celgene Corporation
$48
Grifols USA, LLC
$44
Jazz Pharmaceuticals Inc.
$36
Corium, LLC
$29
Novartis Pharmaceuticals Corporation
$28
Aucta Pharmaceuticals, Inc.
$25
Sage Therapeutics, Inc.
$25
CATALYST PHARMACEUTICALS, INC.
$24
EISAI INC.
$24
HARMONY BIOSCIENCES LLC
$22
ANI Pharmaceuticals, Inc.
$16
Avion Pharmaceuticals
$16
Ipsen Biopharmaceuticals, Inc
$16
Biohaven Pharmaceuticals, Inc.
$15
US WorldMeds, LLC
$12
Top 3 companies account for 80.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · AMYVID · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · Briviact · CREXONT · DUOPA · DYSPORT · Dhivy · EMGALITY · EPIDIOLEX · FIRDAPSE · Fycompa · GOCOVRI · Gamunex-C · Gocovri · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · Leqembi · Motpoly XR · NORTHERA · NOURIANZ · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · ONFI · ONGENTYS 50MG CAPSULES 30 · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · PURIFIED CORTROPHIN GEL · QULIPTA · Qelbree · REXULTI · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · TOSYMRA · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (59%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 7% for neurology in GA.

Looking for a neurology specialist in Austell?
Compare neurologists in the Austell area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
207
Per 100K population
26.9
County median income
$98,712
Nearest hospital
WELLSTAR COBB MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Young is a clinical cardiology specialist, with moderate Medicare volume, with research-focused industry engagement in the top 7% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Young experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Young performed 137 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Young receive payments from pharmaceutical companies?
Yes. Dr. Young received a total of $85,215 from 48 companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Young's costs compare to other neurologists in Austell?
Dr. Young's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Young) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →